FGF23 and chronic kidney disease: In bone, Fgf23 mRNA was lower in the Cre+ mice, and FC alone had a suppressive effect on Fgf23 mRNA in the Cre− mice during CKD (Figure 1b), however other extra‐osseous sources of FGF23, such as liver, showed no differences across groups (Supplemental Figure 1a).